Skip to main content
logo
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
1.070
+0.120 (12.63%)
Oct 29, 2026, 11:29 AM EDT - Market open

Radiopharm Theranostics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
144734122426
Market Cap Growth
-69.81%36.57%192.24%-50.78%-10.18%-
Enterprise Value
92191084
Last Close Price
0.954.194.64---

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
1.375.234.0010.995.74-
PB Ratio
0.793.021.210.640.780.61
P/TBV Ratio
-----5.56

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
0.862.411.119.872.04-

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Debt / Equity Ratio
-0.18-0.18-0.68-0.68-0.26-0.43
Net Debt / EBITDA Ratio
0.080.080.910.570.461.59
Net Debt / FCF Ratio
0.080.080.800.810.502.72
Asset Turnover
0.180.180.160.020.08-
Quick Ratio
1.141.142.651.111.223.43
Current Ratio
1.161.162.671.301.233.46
Return on Equity (ROE)
-174.71%-174.71%-109.20%-131.49%-63.78%-96.82%
Return on Assets (ROA)
-45.15%-45.15%-27.32%-30.36%-22.57%-29.86%
Return on Capital Employed (ROCE)
-128.40%-128.40%-48.40%-65.50%-46.30%-26.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-364.66%-84.57%-73.69%-274.09%-97.15%-79.40%
FCF Yield
-303.32%-78.38%-70.43%-131.34%-65.25%-25.86%
Buyback Yield / Dilution
-47.68%-47.68%-438.49%-26.36%-68.74%-
SEC Filings: 10-K · 10-Q